(Q34294914)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

The use of itraconazole as prophylaxis against invasive fungal infection in blood and marrow transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

invasive fungal infections

9 November 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

S R McCann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

Transplant Infectious Disease

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

72-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Importance of Candida species other than C. albicans as pathogens in oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Itraconazole in cyclodextrin solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Severe vincristine toxicity in combination with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: meeting report. London, United Kingdom, 20 June 1998

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Use of the Quinolones for the Prophylaxis and Therapy of Infections in Immunocompromised Hosts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Hepatotoxicity Associated with Itraconazole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2000.020205.X

7 January 2021

10.1034/J.1399-3062.2000.020205.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11429015%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference